MacArthur Foundation: An End to `Genius Awards' in Science?

Scientists fantasizing about a phone call out of the blue saying that the MacArthur Foundation wants to give them several hundred thousand dollars they haven't even asked for may have to start reworking their daydreams. For when John Corbally retires as president of the $2.5 billion John D. and Catherine T. MacArthur Foundation in May after 10 years on the job, there may well be some changes in the foundation's science funding. Corbally says that the Chicago-based foundation's so-called "geniu

Written byLionel Rolfe
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Corbally says that the Chicago-based foundation's so-called "genius awards" - about a quarter of a million dollars for the recipient to do with pretty much as he or she wants - could be coming to an end in science. MacArthur has been giving out these awards since 1981, and last year nine of the 31 awards went to scientists.

Charles Archambeau, a theoretical geophysicist at the University of Colorado whose work on seismic source theory has had implications for nuclear weapons testing and testing detection. Philip DeVries, a lepidopterist whose work in Costa Rica has been critical for tropical conservation efforts. Helen Edwards, the physicist who heads the accelerator division of Fermi National Accelerator Laboratory. John Fleagle, a primate paleontologist and professor of anatomy at the School of Medicine at SUNY, Stony Brook. Raymond Jeanloz, a geologist interested in mineral physics and high-pressure petrology at the University of California, Berkeley. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies